Considerations for Determining Critical Quality Attributes & Specification for mRNA Therapies

8:30 am - Wednesday 22nd July 2026

More Information to Come Soon!

Speakers:

Eric Levenson
Lead Biologist
FDA/CBER - [Virtual]